{"id":1361,"date":"2026-04-15T15:00:00","date_gmt":"2026-04-15T15:00:00","guid":{"rendered":"https:\/\/lotilabs.com\/resources\/?p=1361"},"modified":"2026-09-07T18:50:26","modified_gmt":"2026-09-07T18:50:26","slug":"thymosin-alpha-1-immune-peptide-research-guide","status":"publish","type":"post","link":"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/","title":{"rendered":"Thymosin Alpha-1: Immune Peptide Research, Mechanisms &#038; Preclinical Findings"},"content":{"rendered":"<div class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-light-blue ez-toc-container-direction\" id=\"ez-toc-container\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a aria-label=\"Toggle Table of Content\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" href=\"#\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg class=\"list-377408\" fill=\"none\" height=\"20px\" style=\"fill: #999;color:#999\" viewbox=\"0 0 24 24\" width=\"20px\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg baseprofile=\"tiny\" class=\"arrow-unsorted-368013\" height=\"10px\" style=\"fill: #999;color:#999\" version=\"1.2\" viewbox=\"0 0 24 24\" width=\"10px\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"><\/path><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class=\"ez-toc-list ez-toc-list-level-1\"><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Chemical_Identity\">Chemical Identity<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Discovery_Story\">Discovery Story<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Mechanism_of_Action\">Mechanism of Action<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Cytokine_Profile\">Cytokine Profile<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Zadaxin_The_Regulatory_Story\">Zadaxin: The Regulatory Story<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Preclinical_Data\">Preclinical Data<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Not_TB-500_Dont_Confuse_Them\">Not TB-500. Don\u2019t Confuse Them.<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Safety_Profile\">Safety Profile<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Where_It_Stands_Legally\">Where It Stands Legally<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Research_Availability\">Research Availability<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Conclusion\">Conclusion<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#References\">References<\/a><\/li><\/ul><\/nav><\/div>\n\n<p><em>For laboratory and research use only. Not for human consumption.<\/em><\/p>\n<p>35+ countries have approved it. The FDA gave it orphan drug status for four separate indications. It\u2019s been studied continuously since 1977. And most Western researchers couldn\u2019t pick it out of a lineup.<\/p>\n<p><a href=\"https:\/\/lotilabs.com\/product\/thymosin-alpha-1-10mg\/\">Thymosin Alpha-1<\/a> \u2014 T\u03b11. 28 amino acids from the thymus gland. It fires up TLR2 and TLR9 simultaneously, matures dendritic cells, pushes T-cell differentiation, and supercharges NK cell killing. The synthetic version goes by thymalfasin (brand name Zadaxin), and it\u2019s been deployed against hepatitis B and C across Asia for years. In America? Investigational. Go figure.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Chemical_Identity\"><\/span><span class=\"ez-toc-section\" id=\"Chemical_Identity\"><\/span>Chemical Identity<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Twenty-eight residues. Acetylated serine at the N-terminus. Derived from prothymosin alpha \u2014 a larger 109-amino acid precursor that thymic epithelial cells chop up and release into circulation.<\/p>\n<ul>\n<li><strong>Sequence:<\/strong> Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN<\/li>\n<li><strong>Molecular Formula:<\/strong> C\u2081\u2082\u2089H\u2082\u2081\u2085N\u2083\u2083O\u2085\u2085<\/li>\n<li><strong>Molecular Weight:<\/strong> 3,108.3 g\/mol<\/li>\n<li><strong>CAS:<\/strong> 62304-98-7<\/li>\n<\/ul>\n<p>Heavily acidic \u2014 loaded with aspartate and glutamate residues. Net negative charge at physiological pH. Same family name. Entirely different biology.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Discovery_Story\"><\/span><span class=\"ez-toc-section\" id=\"Discovery_Story\"><\/span>Discovery Story<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>1960s. Allan Goldstein and Abraham White at Albert Einstein College of Medicine. They\u2019re studying why the thymus gland matters for immune development.<\/p>\n<p>Ten years of purification work later, 1977: they pull out one specific 28-amino acid peptide from that fraction. Thymosin alpha-1. First individual peptide isolated from the thymic mixture that kept its immunological punch. The sequence got mapped. Production in rat thymus was confirmed (Hannappel &amp; Huff, 1984; Proc Natl Acad Sci USA 81:1008-1011).<\/p>\n<p>SciClone Pharmaceuticals later synthesized it as thymalfasin (Zadaxin) \u2014 identical amino acid sequence to the natural peptide. That synthetic version became the basis for regulatory filings across 35+ countries. From crude thymic extract to a defined, synthesized compound with international approvals. Took about three decades.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mechanism_of_Action\"><\/span><span class=\"ez-toc-section\" id=\"Mechanism_of_Action\"><\/span>Mechanism of Action<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Not a one-trick peptide. Multiple receptor targets. Multiple cell types.<\/p>\n<h3>TLR2 + TLR9: Both At Once<\/h3>\n<p>Most immune compounds hit one receptor. T\u03b11 hits two Toll-like receptors on myeloid and dendritic cells.<\/p>\n<p>Through TLR9: MyD88 cascade fires. IRF-7 gets activated. Cells pump out IFN-\u03b1 \u2014 type I interferon. First-line antiviral defense. Through TLR2: NF-\u03baB translocates to the nucleus. Now you\u2019re getting IL-12, TNF-\u03b1, IL-6. Phagocytes wake up. Microbial recognition gets cranked.<\/p>\n<p>The two arms amplify each other. TLR9\u2019s IFN-\u03b1 boosts the scale of TLR2-driven responses. Coordinated, not additive (Romani et al., 2006; Blood 108(7):2265-2274).<\/p>\n<h3>Dendritic Cells: From Immature to Armed<\/h3>\n<p>T\u03b11 matures dendritic cells. MHC class I and II go up. Co-stimulatory molecules (CD80\/CD86) come online. Antigen processing capacity ramps.<\/p>\n<p>But it\u2019s not just activation. T\u03b11 also flips on IDO \u2014 indoleamine 2,3-dioxygenase \u2014 in DCs. That\u2019s tryptophan catabolism. Creates a regulatory environment. Gas pedal and brake at the same time.<\/p>\n<h3>T Cells: The Core Function<\/h3>\n<p>Classic T\u03b11 territory. Thymic progenitors \u2192 functional CD4+ helpers and CD8+ killers. The two pillars of cellular immunity. But there\u2019s more:<\/p>\n<ul>\n<li>Tilts Th1\/Th2 toward Th1 \u2014 cell-mediated over antibody-driven. Th17 and Treg populations also shift<\/li>\n<li>Immunocompromised animals: T-cell counts partially restored. Rosette percentages climb<\/li>\n\n<\/ul>\n<h3>NK Cells<\/h3>\n<p>T\u03b11 activates their killing capacity directly \u2014 activating receptors get upregulated, IFN-\u03b3 production spikes, and there\u2019s synergy with IL-2 for proliferation.<\/p>\n<p>Different immunomodulatory angle: <a href=\"https:\/\/lotilabs.com\/resources\/kpv-peptide-top-benefits-and-uses-for-gut-health-and-inflammation\/\">KPV peptide<\/a> works through alpha-MSH receptors instead.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cytokine_Profile\"><\/span><span class=\"ez-toc-section\" id=\"Cytokine_Profile\"><\/span>Cytokine Profile<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<table>\n<thead>\n<tr><th>Cytokine<\/th><th>Direction<\/th><th>How<\/th><th>What It Means<\/th><\/tr>\n<\/thead>\n<tbody>\n<tr><td>IFN-\u03b1<\/td><td>\u2191<\/td><td>TLR9 \u2192 IRF-7<\/td><td>Antiviral innate response<\/td><\/tr>\n<tr><td>IFN-\u03b3<\/td><td>\u2191<\/td><td>NK and T-cell activation<\/td><\/tr>\n<tr><td>IL-2<\/td><td>\u2191<\/td><td>T-cell cascade<\/td><td>T-cell proliferation<\/td><\/tr>\n<tr><td>IL-10<\/td><td>\u2191<\/td><td>Treg and DC modulation<\/td><\/tr>\n<tr><td>IL-12<\/td><td>\u2191<\/td><td>TLR2 \u2192 NF-\u03baB<\/td><\/tr>\n<tr><td>IL-1\u03b2<\/td><td>\u2193<\/td><td>Inflammasome regulation<\/td><\/tr>\n<tr><td>TNF-\u03b1<\/td><td>\u2193<\/td><\/tr>\n<\/tbody>\n<\/table>\n<p>Protective cytokines go up. Damage cytokines come down. IL-10 \u2014 tolerance \u2014 also rises. It\u2019s an unusually balanced profile. Most immune compounds tilt one direction. That\u2019s rare.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Zadaxin_The_Regulatory_Story\"><\/span><span class=\"ez-toc-section\" id=\"Zadaxin_The_Regulatory_Story\"><\/span>Zadaxin: The Regulatory Story<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Here\u2019s where it stands:<\/p>\n<ul>\n\n<li>Phase II completed for hep B, Phase III for hep C in the US<\/li>\n<li>Not approved in the US (beyond orphan designation), Japan, or most of Europe. Italy is the notable exception<\/li>\n<\/ul>\n<p>Regulatory status varies enormously by country. In the US and EU, T\u03b11 remains investigational.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Preclinical_Data\"><\/span><span class=\"ez-toc-section\" id=\"Preclinical_Data\"><\/span>Preclinical Data<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3>Hepatitis B<\/h3>\n<p>Multiple research groups have examined thymalfasin in HBV models \u2014 Chien et al. (1998), Mutchnick et al. (1999), Zavaglia et al. (2000) \u2014 with varying designs and endpoint measurements.<\/p>\n<h3>Fungal Infections<\/h3>\n<p>TLR2 is a primary receptor for fungal cell wall components. That makes T\u03b11\u2019s TLR2 agonism directly relevant.<\/p>\n\n<p>It\u2019s been studied as an adjunctive agent during immunosuppressive treatment.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Not_TB-500_Dont_Confuse_Them\"><\/span><span class=\"ez-toc-section\" id=\"Not_TB-500_Dont_Confuse_Them\"><\/span>Not TB-500. Don\u2019t Confuse Them.<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>\u201cThymosin\u201d is in both names. That\u2019s where the overlap stops.<\/p>\n<p>T\u03b11: 28 amino acids, 3,108 g\/mol.<\/p>\n<p>TB-500 (thymosin beta-4): 43 amino acids, 4,921 g\/mol.<\/p>\n<p>Same family. Completely different biology.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Safety_Profile\"><\/span><span class=\"ez-toc-section\" id=\"Safety_Profile\"><\/span>Safety Profile<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Favorable across preclinical studies. Key points:<\/p>\n<ul>\n<li>Minimal adverse findings at standard research concentrations in animal models<\/li>\n<li>Thymalfasin studied at 1.6 mg subcutaneous in investigational protocols<\/li>\n<li>Anti-apoptotic: T\u03b11 antagonizes dexamethasone-induced thymocyte death in a time- and concentration-dependent manner (Baumann et al., 2000; Int J Immunopharmacol 22(12):1057-1066)<\/li>\n<li>Standard peptide storage requirements \u2014 temperature and handling matter for bioactivity<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Where_It_Stands_Legally\"><\/span><span class=\"ez-toc-section\" id=\"Where_It_Stands_Legally\"><\/span>Where It Stands Legally<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Approved in Asia and parts of Europe. FDA orphan designation but no US approval. Investigational in Japan and most Western countries except Italy. For research use \u2014 verify your jurisdiction\u2019s rules.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Research_Availability\"><\/span><span class=\"ez-toc-section\" id=\"Research_Availability\"><\/span>Research Availability<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>From Loti Labs:<\/p>\n<ul>\n<li><a href=\"https:\/\/lotilabs.com\/product\/thymosin-alpha-1-10mg\/\">Thymosin Alpha-1 10mg<\/a> \u2014 $79.99<\/li>\n\n<\/ul>\n\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Forty-plus years of data. Approvals on three continents.<\/p>\n<p>For a peptide that\u2019s been studied since 1977 and is still generating new mechanistic insights, T\u03b11 has staying power that most research compounds don\u2019t.<\/p>\n<p><em>For laboratory and research use only. Not for human consumption.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"References\"><\/span><span class=\"ez-toc-section\" id=\"References\"><\/span>References<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Goldstein AL. History of the discovery of the thymosins. <em>Ann N Y Acad Sci.<\/em> 2007;1112:1-13. PMID: 17468229<\/li>\n<li>Romani L, et al. Thymosin alpha 1 activates dendritic cell tryptophan catabolism. <em>Blood.<\/em> 2006;108(7):2265-2274. PMID: 16740584<\/li>\n<li>Hannappel E, Huff T. Thymosins: prothymosin alpha, parathymosin, and beta-thymosins. <em>Vitam Horm.<\/em> 2003;66:257-296. PMID: 12852258<\/li>\n<li>Baumann CA, et al. T\u03b11 antagonizes dexamethasone-induced apoptosis of murine thymocytes. <em>Int J Immunopharmacol.<\/em> 2000;22(12):1057-1066. PMID: 11137614<\/li>\n<li>Garaci E, et al. <em>Expert Opin Biol Ther.<\/em> 2015;15(Suppl 1):S31-S39. PMID: 26096835<\/li>\n<li>Costantini C, et al. Reappraisal of thymosin alpha 1 in cancer research. <em>Front Oncol.<\/em> 2019;9:873. PMID: 31572680<\/li>\n<li>Billich A. Thymosin alpha 1 \u2014 SciClone Pharmaceuticals. <em>Curr Opin Investig Drugs.<\/em> 2002;3(5):698-707. PMID: 12090542<\/li>\n<li>Armutcu F, et al. T\u03b11 attenuates lipid peroxidation in fructose-induced steatohepatitis. <em>Clin Biochem.<\/em> 2005;38(6):540-547.<\/li>\n<li>Yang X, et al. Effect of T\u03b11 on Th1, Th2, Th17, and Treg subpopulations in vitro. <em>Braz J Med Biol Res.<\/em> 2012;45(1):25-32.<\/li>\n<li>Giuliani C, et al. T\u03b11 regulates MHC class I expression at transcriptional level. <em>Eur J Immunol.<\/em> 2000;30(3):778-786.<\/li>\n<li>FDA. Thymosin Alpha-1 Related Bulk Drug Substances. <em>Office of Pharmaceutical Quality Assessment II.<\/em> 2024.<\/li>\n<li>Chien RN, et al. <em>Hepatology.<\/em> 1998;27(5):1383-1387. PMID: 9581696<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Research guide on Thymosin Alpha-1, approved in 35+ countries with FDA orphan drug status. Covers dendritic cell maturation, T-cell activation, TLR signaling, and immunomodulatory mechanisms.<\/p>\n","protected":false},"author":1,"featured_media":1388,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1361","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptides"],"_links":{"self":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/comments?post=1361"}],"version-history":[{"count":0,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1361\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media\/1388"}],"wp:attachment":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media?parent=1361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/categories?post=1361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/tags?post=1361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}